Publication | Closed Access
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.
233
Citations
0
References
2019
Year
PathologyTumor BiologyCancer DetectionMolecular DiagnosticsRadiation OncologyCancer ResearchMolecular OncologyGenetic AlterationsMedicineLung Cancer 19ThTargeted TherapiesCancer TreatmentCancer GeneticsCell BiologyTumor MicroenvironmentLung CancerMultiple Pulmonary NoduleCancer GenomicsBronchial NeoplasmOncologyCancer Growth
The understanding of genetic alterations that drive non-small cell lung cancer (NSCLC) is evolving. As many of these molecularly-defined subtypes are potentially actionable, new strategies in molecular diagnostics and targeted therapies in NSCLC to detect and treat them are being explored. At the International Association for Study of Lung Cancer 19th World Conference, several abstracts and oral presentations related to this topic. In this report, we discuss some of these updates.